Q3 2019 13F Holders as of 9/30/2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
49.8M
-
Number of holders
-
87
-
Total 13F shares, excl. options
-
46.2M
-
Shares change
-
-1.6M
-
Total reported value, excl. options
-
$900M
-
Value change
-
-$26.3M
-
Put/Call ratio
-
0.44
-
Number of buys
-
44
-
Number of sells
-
-38
-
Price
-
$19.48
Significant Holders of Theravance Biopharma, Inc. - Common Stock (TBPH) as of Q3 2019
111 filings reported holding TBPH - Theravance Biopharma, Inc. - Common Stock as of Q3 2019.
Theravance Biopharma, Inc. - Common Stock (TBPH) has 87 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 46.2M shares
of 49.8M outstanding shares and own 92.79% of the company stock.
Largest 10 shareholders include Woodford Investment Management Ltd (11.4M shares), BAUPOST GROUP LLC/MA (9.31M shares), FMR LLC (8.35M shares), VANGUARD GROUP INC (4.01M shares), BlackRock Inc. (3.86M shares), NORGES BANK (956K shares), STATE STREET CORP (948K shares), GEODE CAPITAL MANAGEMENT, LLC (612K shares), Chescapmanager LLC (598K shares), and NORTHERN TRUST CORP (578K shares).
This table shows the top 87 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.